Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France

AstraZeneca

Status: Withdrawn

Conditions: Self-administered Questionnaire to Patients

Study type: Observational

Funder types: Industry

Identifiers

NCT01238809

NIS-CFR-DUM-2010/1

Details and patient eligibility

About

The purpose of this study is to assess in general population low-dose aspirin and gastroprotective agent compliance and reasons for bad compliance

Enrollment: 7,300 estimated patients

Sex: All

Ages: 60+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• French people > 60 years old, part of Kantar Health Access Sant� panel

Exclusion Criteria: -

Trial design

7,300 participants in 1 patient group

1